Literature DB >> 23335518

Surgical management of endometrial cancer. A critical review.

E Halkia1, N Kalinoglou, J Spiliotis.   

Abstract

Endometrial cancer (EC) is a common gynecological malignancy. Prognosis depends on 3 main factors: histological subtype, depth of invasion into the myometrium and lymph node involvement. Surgery remains the gold standard of treatment for this cancer. The aim of this article was to review the surgical approach and the new techniques along with the clarification of some controversial aspects concerning the management of advanced disease stages and the role of lymph node dissection. Surgery of EC remains the treatment of choice in the management of early stage disease. The role of lymph node dissection remains controversial.

Entities:  

Mesh:

Year:  2012        PMID: 23335518

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  1 in total

1.  Metapristone (RU486-derivative) inhibits endometrial cancer cell progress through regulating miR-492/Klf5/Nrf1 axis.

Authors:  Yue Chang; Min Hao; Ru Jia; Yihui Zhao; Yixuan Cai; Yun Liu
Journal:  Cancer Cell Int       Date:  2021-01-07       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.